Literature DB >> 20434439

Protection of retinal pigment epithelium by OT-551 and its metabolite TEMPOL-H against light-induced damage in rats.

Masaki Tanito1, Feng Li, Robert E Anderson.   

Abstract

OT-551 (1-hydroxy-4-cyclopropanecarbonyloxy-2,2,6,6-tetramethylpiperidine hydrochloride), is a novel small molecule with antioxidant and anti-inflammatory effects. Protective efficacy of OT-551 and its metabolite TEMPOL-H (TP-H) against light-induced degeneration of retinal pigment epithelium (RPE) was tested. Albino rats were intraperitoneally injected with OT-551, TP-H, or water approximately 30 min prior to a 6 h exposure to 2700 lux white fluorescent light. Retinal protection was evaluated histologically by counting the RPE cell nuclei and measuring the extent of RPE damage on the retinal sections as RPE damage index (%). Following light exposure, the number of RPE cell nuclei was significantly reduced in light-exposed eyes from water-treated animals, while the number was not significantly different between light-exposed and unexposed eyes from the animals treated with 100 mg/kg TP-H or with any dose of OT-551 in the inferior hemisphere, and with 100 mg/kg OT-551 in the superior hemisphere. RPE damage index was significantly lower in the animals treated with any dose of OT-551 compared to water-treated animals both in the inferior and superior hemispheres. Systemic administration of OT-551 and TP-H provides RPE cell protection against acute light damage, and the protection by OT-551 was greater than by TP-H. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434439      PMCID: PMC3175818          DOI: 10.1016/j.exer.2010.04.012

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  18 in total

1.  Light-induced photoreceptor apoptosis in vivo requires neuronal nitric-oxide synthase and guanylate cyclase activity and is caspase-3-independent.

Authors:  M Donovan; R J Carmody; T G Cotter
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

2.  Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load.

Authors:  Sebastian Thaler; Michal Fiedorowicz; Robert Rejdak; Tomasz J Choragiewicz; Dorota Sulejczak; Piotr Stopa; Tomasz Zarnowski; Eberhart Zrenner; Pawel Grieb; Frank Schuettauf
Journal:  Exp Eye Res       Date:  2009-11-04       Impact factor: 3.467

3.  Retinal damage by light in rats.

Authors:  W K Noell; V S Walker; B S Kang; S Berman
Journal:  Invest Ophthalmol       Date:  1966-10

4.  Biologically active metal-independent superoxide dismutase mimics.

Authors:  J B Mitchell; A Samuni; M C Krishna; W G DeGraff; M S Ahn; U Samuni; A Russo
Journal:  Biochemistry       Date:  1990-03-20       Impact factor: 3.162

5.  Tempol reduces the activation of nuclear factor-kappaB in acute inflammation.

Authors:  Salvatore Cuzzocrea; Barbara Pisano; Laura Dugo; Angela Ianaro; Nimesh S A Patel; Achille P Caputi; Christoph Thiemermann
Journal:  Free Radic Res       Date:  2004-08

6.  The protective effect of ascorbate in retinal light damage of rats.

Authors:  D T Organisciak; H M Wang; Z Y Li; M O Tso
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-11       Impact factor: 4.799

7.  Free radical trap phenyl-N-tert-butylnitrone protects against light damage but does not rescue P23H and S334ter rhodopsin transgenic rats from inherited retinal degeneration.

Authors:  Isabelle Ranchon; Matthew M LaVail; Yashige Kotake; Robert E Anderson
Journal:  J Neurosci       Date:  2003-07-09       Impact factor: 6.167

8.  Attenuation of retinal photooxidative damage in thioredoxin transgenic mice.

Authors:  Masaki Tanito; Hiroshi Masutani; Hajime Nakamura; Shin-ichi Oka; Akihiro Ohira; Junji Yodoi
Journal:  Neurosci Lett       Date:  2002-06-28       Impact factor: 3.046

9.  Tempol-H inhibits opacification of lenses in organ culture.

Authors:  J Samuel Zigler; Chuan Qin; Toshikazu Kamiya; Murali C Krishna; Qiufang Cheng; Santa Tumminia; Paul Russell
Journal:  Free Radic Biol Med       Date:  2003-11-15       Impact factor: 7.376

10.  L-NAME protects against acute light damage in albino rats, but not against retinal degeneration in P23H and S334ter transgenic rats.

Authors:  Ildikó Káldi; Mark Dittmar; Paula Pierce; Robert E Anderson
Journal:  Exp Eye Res       Date:  2003-04       Impact factor: 3.467

View more
  10 in total

Review 1.  Consequences of oxidative stress in age-related macular degeneration.

Authors:  Stuart G Jarrett; Michael E Boulton
Journal:  Mol Aspects Med       Date:  2012-04-09

2.  Light damage in Abca4 and Rpe65rd12 mice.

Authors:  Li Wu; Keiko Ueda; Taka Nagasaki; Janet R Sparrow
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-28       Impact factor: 4.799

Review 3.  Current therapeutic developments in atrophic age-related macular degeneration.

Authors:  Jakub Hanus; Fangkun Zhao; Shusheng Wang
Journal:  Br J Ophthalmol       Date:  2015-11-09       Impact factor: 4.638

4.  Light-induced photoreceptor and RPE degeneration involve zinc toxicity and are attenuated by pyruvate, nicotinamide, or cyclic light.

Authors:  Christian T Sheline; Yongdong Zhou; Shi Bai
Journal:  Mol Vis       Date:  2010-12-08       Impact factor: 2.367

5.  Age-related macular degeneration.

Authors:  Giuseppe Querques; Fernando Onofrio Avellis; Lea Querques; Francesco Bandello; Eric H Souied
Journal:  Clin Ophthalmol       Date:  2011-05-18

6.  A Novel Eye Drop Candidate for Age-Related Macular Degeneration Treatment: Studies on its Pharmacokinetics and Distribution in Rats and Rabbits.

Authors:  Eun-Jeong Choi; Go-Wun Choi; Ju Hee Kim; Hee-Woon Jang; Ju-Hee Lee; Hyun Ju Bae; Young Gwan Kim; Yong-Bok Lee; Hea-Young Cho
Journal:  Molecules       Date:  2020-02-04       Impact factor: 4.411

Review 7.  Nitroxide pharmaceutical development for age-related degeneration and disease.

Authors:  Jacob A Zarling; Vienna E Brunt; Anne K Vallerga; Weixing Li; Albert Tao; David A Zarling; Christopher T Minson
Journal:  Front Genet       Date:  2015-11-06       Impact factor: 4.599

Review 8.  Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.

Authors:  Andrew J Payne; Simon Kaja; Yuliya Naumchuk; Nancy Kunjukunju; Peter Koulen
Journal:  Int J Mol Sci       Date:  2014-01-27       Impact factor: 5.923

Review 9.  The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye.

Authors:  Lixiang Wang; Mikael Ben Zhou; Hui Zhang
Journal:  Ophthalmol Ther       Date:  2021-07-04

Review 10.  Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions.

Authors:  Thales Antonio Cabral de Guimaraes; Malena Daich Varela; Michalis Georgiou; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2021-03-19       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.